Olaf Robert Heyden - 30 Jan 2023 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: EVP, COO
Signature: Jonathan B. Leiken, Attorney in fact for Olaf R Heyden
Issuer symbol: DBD
Transactions as of: 30 Jan 2023
Net transactions value: -$10,295
Form type: 4
Filing time: 01 Feb 2023, 17:03:43 UTC
Previous filing: 10 Mar 2022
Next filing: 07 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBD	Common Shares	Tax liability	$10,295	-4,476	-1.1%	$2.30^*	395,957	30 Jan 2023	Direct	F1, F2
holding	DBD	Common Shares						1,000	30 Jan 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBD	Non-Qualified Stock Option						12,614	30 Jan 2023	Common Shares	12,614	$11.96	Direct	F3
holding	DBD	Non-Qualified Stock Option						47,407	30 Jan 2023	Common Shares	47,407	$4.08	Direct	F3
holding	DBD	Non-Qualified Stock Option						30,278	30 Jan 2023	Common Shares	30,278	$18.75	Direct	F3
holding	DBD	Non-Qualified Stock Options						49,650	30 Jan 2023	Common Shares	49,650	$26.60	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2	Number includes restricted stock units.
F3	Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F4	Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.